BOSTON, April 13, 2022 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted oncology company forging new territory in patient-directed cancer treatment, today announced the ...
GAITHERSBURG, Md., April 08, 2026 (GLOBE NEWSWIRE)-- Remedy Plan Therapeutics, a clinical-stage biotechnology company developing novel therapies that target fundamental metabolic vulnerabilities in ...
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--ROTH Capital Partners (“ROTH”), www.roth.com, a full service investment bank focused on serving emerging growth companies and their investors, today announced ...
Ikena Oncology , Inc. (NASDAQ:IKNA), a biotechnology company with a market capitalization of $61.29 million and strong financial health according to InvestingPro analysis, announced Tuesday an ...
(RTTNews) - Ikena Oncology, Inc. (IKNA) announced the appointment of Jotin Marango to Chief Financial Officer and Head of Corporate Development. Marango joins the company from Aptose Biosciences, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results